GESTIÓN EN SALUD PÚBLICA: Risk of tizanidine-induced adverse events after concomitant exposure to ciprofloxacin: A cohort study in the U.S - PubMed

miércoles, 11 de mayo de 2022

Risk of tizanidine-induced adverse events after concomitant exposure to ciprofloxacin: A cohort study in the U.S - PubMed

Risk of tizanidine-induced adverse events after concomitant exposure to ciprofloxacin: A cohort study in the U.S - PubMed

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)